Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dihydroartemisinin + piperaquine for uncomplicated Plasmodium falciparum malaria in Bosaso, Puntland, Somalia
ACTRN12616000553471Phase 4Completed
- Sponsor
- Ministry of Health of Puntland
- Start
- Jan 2016
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of dihydroartemisinin and piperaquine in Malaria, sponsored by Ministry of Health of Puntland. Primary endpoints: Percent of treatment failures, Adequate clinical and parasitological response and 1 more. Started Jan 2016; status: completed.
02
Drugs
dihydroartemisininpiperaquine
03
Conditions
Malaria
Beyond the preview
Go deeper on ACTRN12616000553471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616000553471.